Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

February 28, 2021
Open Access

Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.

Kidney International
Alfred K CheungJohannes F E Mann
February 28, 2021

Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.

Shruti S JoshiJagdeep Singh
February 28, 2021

Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis.

International Journal of Obesity : Journal of the International Association for the Study of Obesity
Seyed Morsal Mosallami AghiliMoloud Payab
February 28, 2021

Lipid metabolism in cartilage and its diseases: a concise review of the research progress.

Acta Biochimica Et Biophysica Sinica
Yueyi YangJing Xie
February 28, 2021

Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland.

Swiss Medical Weekly
Amaury ThiabaudOlivia Keiser
February 28, 2021

Preeclampsia and long-term health outcomes for mother and infant: An umbrella review.

BJOG : an International Journal of Obstetrics and Gynaecology
Theodora PittaraKonstantinos Giannakou
February 28, 2021

Effects of Simvastatin on Tissue Factor Pathway of Blood Coagulation in STATCOPE (Simvastatin in the Prevention of COPD Exacerbations) Trial.

Journal of Thrombosis and Haemostasis : JTH
A Koneti RaoNIH COPD Clinical Research Network, the Canadian Institute of Health Research Investigators
February 27, 2021

Effects of Metformin-Single Therapy on the Level of Inflammatory Markers in Serum of Non-Obese T2DM Patients with NAFLD.

Endocrine, Metabolic & Immune Disorders Drug Targets
Bojan MitrovicEsma R Isenovic
February 27, 2021
Open Access

Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia.

Journal of Translational Medicine
Youhyun SongKyung-Won Hong
February 27, 2021

Emerging role of protein kinases in diabetes mellitus: From mechanism to therapy.

Advances in Protein Chemistry and Structural Biology
Preeti GuptaMd Imtaiyaz Hassan
February 27, 2021

Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study.

Diabetes Care
Sareh KeshavarziDCCT/EDIC Research Group
February 27, 2021

Comparison of coronary artery bypass graft versus drug-eluting stents in dialysis patients: an updated systemic review and meta-analysis.

Journal of Cardiovascular Medicine
Narut PrasitlumkumRonpichai Chokesuwattanaskul
February 27, 2021

Insulin Resistance as a Diagnostic Criterion for Metabolically Healthy Obesity in Children.

Journal of Pediatric Gastroenterology and Nutrition
Ana Pilar Nso-RocaFrancisco Sánchez Ferrer
February 27, 2021
Open Access

Thyroid Dysfunction in Patients Admitted in Cardiac Care Unit: Prevalence, Characteristic and Hospitalization Outcomes.

International Journal of General Medicine
Abdulrahman AlQahtaniKhaled Alswat
February 27, 2021
Open Access

Angiogenesis in Adipose Tissue: The Interplay Between Adipose and Endothelial Cells.

Frontiers in Physiology
Jacqueline Herold, Joanna Kalucka
February 27, 2021
Open Access

Very Low Prevalence and Incidence of Atrial Fibrillation among Bolivian Forager-Farmers.

Annals of Global Health
Christopher J RowanMichael D Gurven
February 27, 2021
Open Access

Palliative Care for People Living With Heart Disease-Does Sex Make a Difference?

Frontiers in Cardiovascular Medicine
Piotr Z SobanskiSarah J Goodlin
February 27, 2021
Open Access

Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond.

Cardiovascular Endocrinology & Metabolism
Sejal LahotiRobert Chilton

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2021 Meta ULC. All rights reserved